Announcements Trials
Browse Landscape

Phase

Phase NA 50Phase 2 11Phase 1 7Phase 3 4Phase EARLY_PHASE1 3Phase 2/3 2Phase 1/2 1

Status

Withdrawn 2Completed 2

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Gynecologic 1Dermatologic 1

Conditions

Breast Neoplasms 2Melanoma 1Endometrial Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Sentinel Lymph Node Biopsy × Clear all
NCT01826864 2020-07-27

Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma

Jonsson Comprehensive Cancer Center

Phase 3 Withdrawn
Dermatologic

Melanoma

NCT01796444 2018-04-05

Z0011-China

Shandong Cancer Hospital and Institute

Phase 3 Withdrawn
Breast

Breast Neoplasms

NCT02564276 2018-01-25

Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 3 Completed
132 enrolled
Gynecologic

Endometrial Neoplasms

NCT00003854 2016-07-13

Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
4,590 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡